Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyams

Showing results (841-850 of 936) with videos related to

Pageof 94
Sort By:
Pediatric Radiology|July 3, 2025
Baseline terminal ileal CT and MRI measurements are associated with imaging outcomes in pediatric Crohn's disease: a cohort studyAllison D Ta, Jonathan R Dillman, Nicholas J Ollberding, et al.
Pediatrics|June 5, 2007
Laboratory values for children with newly diagnosed inflammatory bowel diseaseDavid R Mack, Christine Langton, James Markowitz, et al.
The American Journal of Gastroenterology|September 3, 2009
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's diseaseJoel R Rosh, Trudy Lerer, James Markowitz, et al.
The AAPS Journal|March 21, 2013
CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug productsCelia N Cruz, Katherine M Tyner, Lydia Velazquez, et al.
Hepatology Communications|November 9, 2020
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver DiseaseSimon Lam, Ruchi Singh, Jonathan R Dillman, et al.
Gut|April 14, 2019
Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentaryDan Turner, Anne M Griffiths, David Wilson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2006
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's diseaseJames Markowitz, Jeffrey Hyams, David Mack, et al.
The American Journal of Surgical Pathology|September 2, 2017
Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative ColitisBrendan Boyle, Margaret H Collins, Zhu Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2023
Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score NormalizationDuke Geem, David Hercules, Ranjit S Pelia, et al.
Journal of the Royal Society of Medicine|July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adultsCatherine Hyams, George Qian, George Nava, et al.
Pageof 94

Showing results (841-850 of 936) with videos related to

Sort By:
Pageof 94
Pediatric Radiology|July 3, 2025
Baseline terminal ileal CT and MRI measurements are associated with imaging outcomes in pediatric Crohn's disease: a cohort studyAllison D Ta, Jonathan R Dillman, Nicholas J Ollberding, et al.
Pediatrics|June 5, 2007
Laboratory values for children with newly diagnosed inflammatory bowel diseaseDavid R Mack, Christine Langton, James Markowitz, et al.
The American Journal of Gastroenterology|September 3, 2009
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's diseaseJoel R Rosh, Trudy Lerer, James Markowitz, et al.
The AAPS Journal|March 21, 2013
CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug productsCelia N Cruz, Katherine M Tyner, Lydia Velazquez, et al.
Hepatology Communications|November 9, 2020
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver DiseaseSimon Lam, Ruchi Singh, Jonathan R Dillman, et al.
Gut|April 14, 2019
Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentaryDan Turner, Anne M Griffiths, David Wilson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2006
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's diseaseJames Markowitz, Jeffrey Hyams, David Mack, et al.
The American Journal of Surgical Pathology|September 2, 2017
Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative ColitisBrendan Boyle, Margaret H Collins, Zhu Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2023
Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score NormalizationDuke Geem, David Hercules, Ranjit S Pelia, et al.
Journal of the Royal Society of Medicine|July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adultsCatherine Hyams, George Qian, George Nava, et al.
Pageof 94